Evidence map›Paper›PMID 40617972›Full record

ReviewGenes and immunity2025

Regulation of CD4 + T cell differentiation and function by glucose metabolism.

Yubo Liu, Yiwen Zhou, Ji Zhang, Jingyi Li, Liyun Zou

Abstract readReview
PubMed Publisher
In one paragraph

Review in Genes and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. CD4Cancer biology & medicine · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yubo Liu *Department of Immunology, Army Medical University, Chongqing, China.
Yiwen Zhou *Department of Immunology, Army Medical University, Chongqing, China.
Ji ZhangDepartment of Immunology, Army Medical University, Chongqing, China.
Jingyi LiDepartment of Rheumatology and Immunology, Southwest Hospital, Army Medical University, Chongqing, China. lijingyi2@tmmu.edu.cn.
Liyun ZouDepartment of Immunology, Army Medical University, Chongqing, China. zouliyun@tmmu.edu.cn.ORCID 0000-0001-5449-8869

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32270987National Natural Science Foundation of China (National Science Foundation of China) 82171787National Natural Science Foundation of China (National Science Foundation of China) 82371820
6 · The paper itself

Abstract

The long-term persistence of naive T lymphocytes is maintained by a state of relative quiescence. Upon antigenic stimulation, these naive T cells undergo rapid activation and proliferation, differentiating into effector cells with specific clonal expansion. Recently, in-depth studies have revealed a fundamental difference in the metabolic requirements of distinct T cell subsets. The fate of CD4 + T cells is influenced by glucose-mediated glycolysis and oxidative phosphorylation (OXPHOS). In this context, key enzymes and various glycolytic intermediates, in conjunction with transcription factors and cytokines, play a crucial role in CD4 + T cell differentiation and function. In our study, we investigated the mechanisms underlying glycolytic reprogramming in CD4 + T cells, with a particular focus on the role of glycolytic enzymes in modulating cytokines and transcription factors that govern T cell differentiation.Our aim is to provide novel insights into the treatment of clinically relevant immune diseases by thoroughly elucidating the characteristics and potential regulatory mechanisms of glucose metabolism in CD4 + T cells.

Indexed as

CD4-Positive T-LymphocytesCell DifferentiationGlucoseAnimalsGlycolysisHumansLymphocyte ActivationOxidative PhosphorylationGlucose

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.